AVTR · Avantor Inc
Price
Snapshot
50 fields · last close| Market Cap | $10.38B |
| P/E | — |
| Float | 650.7M |
| Beta | 0.98 |
| Volatility | 24.5% |
| Exchange | NYSE |
| Sector | Life Sciences Tools & Services |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 69.2 |
| Price | 15.34 |
| Change | +0.00% |
| Prev Close | 15.34 |
| Open | 15.11 |
| Day Low | 14.96 |
| Day High | 15.38 |
| Avg Vol | 9 |
| Avg $ Vol | $144.7M |
| 52W High | 16.05 |
| 52W Low | 7.26 |
| 52W Pos | 91.9% |
| From High | −4.42% |
| From Low | +111.15% |
| Max DD 1Y | −52.50% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +1.00% |
| SMA 50 | +6.78% |
| SMA 200 | +42.89% |
| RSI (14) | 58.1 |
| Vol 30D | 28.8% |
| Vol 90D | 47.1% |
| 1Y Range | 7–16 |
| Daily bars | 900 |
| Perf Week | +0.59% |
| Perf Month | +4.71% |
| Perf Quarter | +47.93% |
| Perf Half Y | +94.18% |
| Perf Year | +12.22% |
| Perf YTD | +33.86% |
| Prev Day | +0.00% |
| Clavix | B- |
| Debt / Eq | 0.71 |
| Curr Ratio | 1.78 |
| Int Cover | -1.8× |
| FCF Margin | 7.5% |
| Rev Growth | −3.4% |
| Profit | Unprofitable |
| Leverage | Moderate |
| Sector rank | 13 / 19 |
Clavix risk grade
regraded every trading dayAVTR grades B-, 69.2 of 100. Steadiest on Sector Resilience (67), most exposed on Price Stability (51, mixed). 2 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 13 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| AVTR | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.98 | 1.18 |
| Volatilityannualized | 24.5% | 29.4% |
| Max drawdown, past yearworst peak-to-trough fall | −52.5% | — |
| Typical daily movemedian absolute daily change | 1.44% | — |
| Days beyond ±3%of the last 252 sessions | 56 (22%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| AVTR | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.98 | 1.18 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 47% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| AVTR | |
|---|---|
| 1 week | +0.6% |
| 1 month | +4.7% |
| Year to date | +33.9% |
| 1 year | +12.2% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| AVTR | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 28 Jul |
| Average score0 most bearish, 100 most bullish | 66 |
| Bullish · bearisharticles above 60 · below 40 | 22 · 2 |
| Directionarticles whose tone is improving vs worsening | 22 ↑ 2 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| AVTR | |
|---|---|
| Revenue growthyear over year | −3.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openWall Street Zen, an investment research firm, lowered its rating on Avantor (AVTR) from "buy" to "hold" in a report issued Saturday. No business reason for the change was given.
Avantor has named Todd Garner as its new Executive Vice President and Chief Financial Officer, effective September 21, 2026. He will run Avantor's global finance organization, covering planning, accounting, treasury, tax, investor relations and internal audit, and brings roughly 30 years of finance leadership including prior CFO roles.
Avantor has appointed Todd Garner as its new Executive Vice President and Chief Financial Officer. Garner previously served as CFO of CONMED and brings more than 30 years of operating and public-company experience to Avantor, a life sciences tools supplier.
Avantor appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner previously served as EVP and CFO of CONMED Corporation from 2018 to 2026 and brings over 30 years of finance and operational leadership experience, including prior roles at C. R. Bard.
Avantor announced on September 17, 2026 that it has appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner, age 57, previously served as CFO of medical technology company CONMED Corporation from January 2018 to March 2026 and held several finance roles at C.R. Bard from 2003 to 2017.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| RGEN | Repligen Corp | B- | $10.25B | 246.86 | 1.13 | Compare |
| BRKR | Bruker Corp | C | $9.64B | — | 1.24 | Compare |
| TECH | Bio-Techne Corp | B | $11.35B | 62.43 | 1.29 | Compare |
| QGEN | Qiagen NV | B+ | $9.22B | 22.53 | 0.59 | Compare |
| TXG | 10X Genomics Inc | C- | $12.18B | — | 2.01 | Compare |
| TEM | Tempus AI Inc | D- | $13.83B | — | 2.25 | Compare |
| CRL | Charles River Laboratories International Inc | B- | $13.85B | — | 1.38 | Compare |
| MEDP | Medpace Holdings Inc | B | $16.73B | 34.04 | 1.11 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.